Stephanie Infante

Stephanie Infante practices at East End Neurpsych in Centereach, New York.

Stephanie Infante's NPI, 1417684143, was assigned on August 3, 2022. Stephanie Infante graduated from Stony Brook University Health Sciences Center School of Medicine in 2022. Stephanie Infante holds New York license 677998.

Stephanie Infante's primary practice is East End Neurpsych, at 2539 Middle Country Rd Suite 4 Suite 4, Centereach, NY 11720-3503. The practice phone is (631) 737-6434.

Stephanie Infante's primary practice is East End Neurpsych in Centereach, New York. The medical group on file is East End Neuropsych, P.C.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephanie Infante practices. Vendor and product names are available with a free account.

Geriatric psychiatry is Stephanie Infante's primary specialty in the NPI Registry, under taxonomy code 2084P0805X. Stephanie Infante is licensed in New York.

CMS data shows 2,208 Medicare services from Stephanie Infante across 8 procedure codes in 2024, for 384 Medicare patients. Medicare paid $171,710 for them. Every service was in an office.

CMS counts 384 Medicare patients who saw Stephanie Infante in 2024. The largest group is 75 to 84, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Stephanie Infante's median patient age at 79, with 73% women.

In 2024, Stephanie Infante wrote 2,920 Medicare Part D claims for 398 patients. 90% of them were for generic drugs. CMS names the drug for 2,711 of them, across 44 drugs with 11 or more claims each, at $505,024 in total drug cost. In 2023, CMS named 2,176 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Stephanie Infante for performance year 2024, reported as part of a group. Stephanie Infante accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stephanie Infante as offering telehealth.

CMS Open Payments shows 145 general payments to Stephanie Infante from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $585.

Stephanie Infante graduated from Stony Brook University Health Sciences Center School of Medicine in 2022.